These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 3581077
1. Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas. Evelhoch JL, Keller NA, Corbett TH. Cancer Res; 1987 Jul 01; 47(13):3396-401. PubMed ID: 3581077 [Abstract] [Full Text] [Related]
2. In vivo 31P-nuclear magnetic resonance study of the response of a murine mammary tumor to different doses of gamma-radiation. Sijens PE, Bovée WM, Seijkens D, Los G, Rutgers DH. Cancer Res; 1986 Mar 01; 46(3):1427-32. PubMed ID: 3943104 [Abstract] [Full Text] [Related]
3. Changes in 31P nuclear magnetic resonance with tumor growth in radioresistant and radiosensitive tumors. Koutcher JA, Alfieri AA, Barnett DC, Cowburn DC, Kornblith AB, Kim JH. Radiat Res; 1990 Mar 01; 121(3):312-9. PubMed ID: 2315448 [Abstract] [Full Text] [Related]
4. Dose-dependent metabolic response of mammary carcinoma to photodynamic therapy. Chopp M, Hetzel FW, Jiang Q. Radiat Res; 1990 Mar 01; 121(3):288-94. PubMed ID: 2315447 [Abstract] [Full Text] [Related]
5. Dietary fat modulation of murine mammary tumor metabolism studied by in vivo 31P-nuclear magnetic resonance spectroscopy. Buckman DK, Erickson KL, Ross BD. Cancer Res; 1987 Nov 01; 47(21):5631-6. PubMed ID: 3664470 [Abstract] [Full Text] [Related]
7. Murine mammary tumor response to hyperthermia and radiotherapy evaluated by in vivo 31P-nuclear magnetic resonance spectroscopy. Sijens PE, Bovée WM, Seijkens D, Koole P, Los G, van Rijssel RH. Cancer Res; 1987 Dec 15; 47(24 Pt 1):6467-73. PubMed ID: 3677087 [Abstract] [Full Text] [Related]
10. Use of high-resolution 31P-labeled topical magnetic resonance spectroscopy to monitor in vivo tumor metabolism in rats. Irving MG, Simpson SJ, Field J, Doddrell DM. Cancer Res; 1985 Feb 15; 45(2):481-6. PubMed ID: 3967223 [Abstract] [Full Text] [Related]
13. Characterization of the 31P nuclear magnetic resonance spectrum from human melanoma tumors implanted in nude mice. Corbett RJ, Nunnally RL, Giovanella BC, Antich PP. Cancer Res; 1987 Oct 01; 47(19):5065-9. PubMed ID: 3621191 [Abstract] [Full Text] [Related]
14. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma. Winter PM, Poptani H, Bansal N. Cancer Res; 2001 Mar 01; 61(5):2002-7. PubMed ID: 11280759 [Abstract] [Full Text] [Related]
15. Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide and irradiation with 10 MeV electrons--verification of the therapeutic results with 31P-NMR spectroscopy. Ulmer W. Strahlenther Onkol; 1991 Sep 01; 167(9):553-60. PubMed ID: 1925940 [Abstract] [Full Text] [Related]
16. 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors. Constantinidis I, Braunschweiger PG, Wehrle JP, Kumar N, Johnson CS, Furmanski P, Glickson JD. Cancer Res; 1989 Nov 15; 49(22):6379-82. PubMed ID: 2804984 [Abstract] [Full Text] [Related]
17. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow. Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK. Clin Cancer Res; 2000 Apr 15; 6(4):1498-507. PubMed ID: 10778982 [Abstract] [Full Text] [Related]